Main Indications and Therapeutic Uses

Diosminex Max is primarily used to manage symptoms associated with chronic venous insufficiency and disorders of the microcirculation. Its active ingredient, micronized diosmin, is utilized to address structural and functional issues in the veins of the lower limbs and the rectal area.

Chronic Venous Insufficiency (CVI)

The medication is indicated for the treatment of symptoms resulting from weakened vein walls and valves in the legs. These conditions often manifest as a feeling of heaviness, discomfort, or aching in the lower extremities. Specific symptoms addressed include:

• Leg heaviness and fatigue: Often described as a weighted sensation that worsens throughout the day.
• Pain and discomfort: General aching or localized soreness in the legs.
• Nighttime cramps: Involuntary muscle contractions that occur during rest.
• Restless legs: A persistent urge to move the limbs, particularly in the evening.

Management of Varicose Veins and Edema

Diosminex Max is used to help manage the visible and physical complications of venous hypertension. By supporting venous tone, it assists in reducing:

• Swelling (Edema): The accumulation of fluid in the ankles and lower legs.
• Spider veins and varicose veins: Peripheral vascular changes caused by persistent venous pressure.

Acute Hemorrhoidal Disease

The pharmacological properties of the medication also extend to the treatment of symptoms associated with hemorrhoidal crisis. It is used as a supportive measure to alleviate the pressure and discomfort localized in the rectal venous plexus during acute episodes.

Benefits and Mechanism of Action

The clinical benefit of Diosminex Max is derived from its effect on the vascular system. The micronization of the active substance allows for more efficient absorption, leading to several physiological benefits:

• Venous Tone Enhancement: It increases the tension of the venous walls, which helps prevent blood from pooling in the lower extremities.
• Microcirculation Protection: It helps reduce the permeability of small blood vessels (capillaries), protecting them from leakage and fragility.
• Anti-inflammatory Support: It assists in inhibiting the inflammatory processes that contribute to the degradation of venous valves and vessel walls.

Eligibility Map: Who can and cannot use Diosminex Max — official regulatory information

This section defines the populations eligible and restricted for use based on official regulatory labeling.

---

Eligibility Scope

Classification	Population/Condition
Populations for whom use is allowed	Individuals with symptoms of venolymphatic insufficiency (such as heavy legs, pain, and nocturnal cramps) or functional signs related to acute haemorrhoids.
Populations for whom use is contraindicated	Hypersensitivity (allergy) to diosmin or any of the product's excipients.
Physiological Restrictions (Not Recommended)	Lactating women (due to a lack of data on whether the substance passes into breast milk). Pregnant women, unless strictly necessary, as sufficient data to exclude risk is not available.
Age-related rules	Pediatric use is generally not addressed in the core regulatory documentation, implying use is reserved for adults.

---

Eligibility-Context Constraints

Official documents highlight that treatment for acute haemorrhoids must be of short duration. If symptoms do not resolve quickly, a medical examination is required. The product also contains the excipient Cochineal Red A (E 124), an azoic agent which may induce allergic reactions, posing a restriction for sensitive individuals. The overall regulatory profile is characterized by a formal contraindication against known hypersensitivity and a strong recommendation against use in pregnancy and lactation due to insufficient safety data.

Interactions with other medicines and products

Official regulatory information indicates that Diosmin, the active component, has the potential for drug-drug interactions, primarily through its metabolic breakdown product. This potential necessitates caution when co-administering with certain drug classes.

---

Pharmacokinetic Interactions (Exposure Modification)

Classification	Potential Effect	Interacting Products/Classes
Metabolic Pathway	May increase the plasma concentration of co-administered drugs.	Medicines metabolized by Cytochrome P450 enzymes, particularly CYP2C9, CYP2E1, and CYP3A4 substrates.
Transporters	May increase the absorption or systemic concentration of co-administered drugs.	Medicines transported by P-glycoprotein (P-gp) or other cellular efflux pumps (e.g., Fexofenadine).

---

Pharmacodynamic Interactions (Effect Modification)

Co-administration with medicines that slow blood clotting may pose a risk. Diosmin has been associated with effects on platelet aggregation. Therefore, concurrent use with anticoagulant or antiplatelet medicines (such as warfarin) requires monitoring for signs of increased bruising or bleeding, as documented in clinical reports.

---

Interaction-Related Restrictions and Constraints

• Anticoagulation Therapy: Patients receiving long-term anticoagulant treatment should be closely monitored by a healthcare professional if Diosminex Max is initiated. Increased vigilance for hemorrhage is required.
• Carbamazepine: Specific data suggests that Diosmin may increase the exposure of Carbamazepine, a medicine metabolized by the CYP3A4 pathway, which may lead to enhanced effects and potential side effects.

Enhanced Venous Tone and Hemodynamics

The mechanism primarily acts to modulate the responsiveness of venous smooth muscle cells to natural signals, such as norepinephrine. This potentiating effect enhances the tone of the peripheral veins and reduces their capacitance, a physiological change that promotes a faster rate of blood flow (venous return) and contributes to a reduction in venous stasis.

---

Vascular Protection and Anti-Inflammatory Modulation

Diosmin engages mechanisms that stabilize the microcirculation, acting on the endothelial lining and reducing its hyperpermeability. Concurrently, it inhibits the activation of key inflammatory pathways ( like NF-kappa B), which suppresses the release of pro-inflammatory mediators and limits leukocyte adhesion to the vessel walls, which results in the preservation of normal microvascular integrity.

---

Mechanism Context and Physiological Scope

The mechanistic effect is enabled by the micronized formulation, which facilitates the systemic delivery required to engage the molecular targets. The resulting physiological effects include reduced fluid filtration out of the capillaries and enhanced lymphatic peristalsis (contraction). The dual mechanism facilitates a more controlled exchange of fluid across the capillary walls.

This medication is consistently administered via the oral route as a 1000 mg film-coated tablet, with all official regimens intended for use in adult patients only. The general principle of usage requires that the tablet be taken at mealtime to ensure proper administration conditions, which often means taking the single daily dose in the morning when used for chronic conditions.

The prescribed dosing structure is dependent on the clinical scenario, defining two distinct patterns. For the supportive management of chronic venous insufficiency, the standard administration is 1 tablet once daily, and this usage pattern is typically followed for long-term courses lasting several months. In contrast, the administration for an acute hemorrhoidal attack follows a strict seven-day stepped protocol. This short-term protocol requires a higher loading dose of 3 tablets per day for the initial four days, followed by a tapering dose of 2 tablets per day for the subsequent three days, with the daily quantity divided across multiple intakes.

A key procedural constraint is that the tablet’s score line, while present, is only to facilitate swallowing and does not permit division into equal doses for accurate numerical measurement. No specific dose adjustments for elderly, renal, or hepatic impairment are detailed in the primary posology.

Diosminex Max: Recent Clinical Evidence

Diosmin is a flavonoid compound derived from citrus fruits that has been investigated for its use in chronic venous disorders (CVD), including chronic venous insufficiency and hemorrhoids. Studies suggest it supports the microcirculation and promotes venous tone, which may help manage symptoms associated with impaired circulation.

---

Clinical Efficacy in Venous Disorders

Multiple randomized controlled trials (RCTs) have examined the effectiveness of diosmin in individuals with CVD, often focusing on symptoms such as leg pain, heaviness, and edema (swelling). The results of these trials generally indicate that diosmin therapy is associated with:

• Reduction in Edema: A reported decrease in leg circumference, suggesting a reduction in swelling compared to placebo or baseline measurements.
• Symptom Improvement: Better scores on patient-reported pain scales and overall quality of life assessments, particularly regarding leg heaviness and cramps.

---

Tolerability and Safety Profile

Diosmin is generally reported to be well-tolerated when used at standard doses. The majority of adverse events observed in clinical studies are typically mild and transient. Commonly reported side effects have included:

System	Common Side Effects (Reported)
Gastrointestinal	Stomach pain, diarrhea, nausea, dyspepsia
Neurological	Headaches, dizziness
Dermatological	Rash, skin redness, or hives

Serious adverse events are rare. It is important to note that diosmin may interact with certain medications, including some blood thinners and drugs metabolized by the liver, potentially altering their effects.

Common questions about Diosminex Max (FAQ)

Q: What is Diosminex Max?

A: Diosminex Max is a medication containing the active substance micronized diosmin, which belongs to a group of medicines called venous protectors (protecting vein walls) and venotonic medicines (increasing vein tone). It is typically used for managing symptoms associated with chronic venous insufficiency and hemorrhoids.

---

Q: What are the main uses of Diosminex Max?

A: Diosminex Max is used in adults for:

• Relieving symptoms of chronic venous insufficiency in the legs, such as: leg pain, a feeling of heavy legs, or night-time leg cramps.
• Symptomatic treatment of pain, bleeding, or other discomfort associated with hemorrhoids.

---

Q: How does diosmin, the active ingredient, work?

A: Diosmin works in two main ways to benefit the vascular system:

1. It increases venous tone: It enhances the tension and contractility of the vein walls, which helps to reduce the pooling of blood (venous stasis).
2. It protects blood vessels: It reduces the excessive permeability (leakiness) of small blood vessels (capillaries) and has an anti-inflammatory effect on the vessel walls.

This combined action helps to improve blood flow and reduce symptoms like swelling and heaviness in the legs.

---

Q: What is chronic venous insufficiency and what are its symptoms?

A: Chronic venous insufficiency (CVI) is a condition where the veins in the legs have trouble sending blood back to the heart. This leads to blood pooling in the legs.

The symptoms that Diosminex Max is used to treat include:

• A sensation of heavy legs.
• Pain in the legs.
• Night-time leg cramps.
• Swelling (edema) of the legs and ankles.

---

Q: Can Diosminex Max be used for hemorrhoids?

A: Yes, Diosminex Max is indicated for the symptomatic treatment of hemorrhoids. It is used to relieve symptoms such as pain, discomfort, and bleeding associated with hemorrhoidal attacks.

---

Q: Is the active ingredient, diosmin, synthetic or natural?

A: Diosmin is a naturally occurring flavonoid derived from plants, particularly from the rinds of citrus fruits. For use in medicines like Diosminex Max, it undergoes a process called micronization. This process reduces the particle size of the diosmin to ensure better absorption by the body, which can increase its effectiveness.

---

Q: Does Diosminex Max require a prescription?

A: The requirement for a prescription for Diosminex Max can vary by country, as regulatory status differs internationally. In some places, it is available as an over-the-counter (OTC) medicine, while in others, it may require a prescription. Patients should check the regulatory status in their specific location or consult with a local pharmacist.

---

Q: Are there common side effects associated with Diosminex Max?

A: Like all medicines, Diosminex Max may cause side effects, although not everybody gets them. The most common side effects are generally mild and may include:

• Gastrointestinal disturbances, such as diarrhea, nausea, vomiting, or indigestion (dyspepsia).

Less common side effects can include dizziness, headache, or malaise. If you experience serious side effects or a worsening of your condition, you should seek medical advice.

---

Q: What should I do if I miss a dose?

A: If you miss a dose of Diosminex Max, you should take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.

Storage and Disposal Requirements

Official regulatory documents define specific conditions that must be followed to ensure the quality of Diosminex Max and safe disposal.

---

Storage Constraints

The medication must be stored at a temperature that does not exceed 25 C (77 F). A critical safety requirement mandates that the tablets be kept in a place invisible and inaccessible to children to prevent accidental ingestion. The product must not be used after the expiry date (EXP) printed on the packaging.

Disposal Rules

For environmental protection, the medicine must not be thrown away via household waste bins or wastewater. Users are instructed to consult a pharmacist regarding the proper disposal of unused or expired tablets, ensuring adherence to local pharmaceutical waste collection procedures.